Financial News
Moderna COVID-19 vaccine doubles level of antibodies versus Pfizer shot: study
August 31, 2021 at 09:16 AM EDT
Moderna’s COVID-19 vaccine more than doubled the level of antibodies compared to the Pfizer vaccine, according to a study of healthcare workers in Belgium, researchers found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
